Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EF-hand calcium-binding domain-containing protein 5 (EFCAB5) is a large protein (1503 amino acids) characterized by the presence of EF-hand motifs, which are helix–loop–helix structural domains capable of binding calcium ions[4][2][3]. The protein belongs to the diverse superfamily of EF-hand calcium-binding proteins, which are generally involved in calcium ion sensing, buffering, and signal transduction within the cell[5][3][1]. EFCAB5 is a predicted calcium-binding protein, but there are no published data confirming its direct therapeutic target potential or role as a receptor or enzyme, and no known interacting drugs or mechanisms of pharmaceutical action are reported[4]. Although evidence links EFCAB5 to disease associations such as autism spectrum disorder and brain sarcoma, its precise cellular or molecular functions and mechanistic disease contributions remain unclear[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EF-hand calcium-binding domain-containing protein 5 (EFCAB5).